Carriers of damaging ACE mutations exhibited a trend toward higher rates of dementia, hippocampal dysfunction, and frontal dysfunction compared to non-carriers, indicating a possible increased risk of these cognitive impairments. The gene discussed is ACE; the disease is Cognitive impairment.